Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-202743
Filing Date
2025-09-15
Accepted
2025-09-15 06:49:19
Documents
166
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 20-F opt-20250630.htm   iXBRL 20-F 7683504
2 EX-4.19 opt-ex4_19.htm EX-4.19 140085
3 EX-4.20 opt-ex4_20.htm EX-4.20 136532
4 EX-4.21 opt-ex4_21.htm EX-4.21 152413
5 EX-4.22 opt-ex4_22.htm EX-4.22 300486
6 EX-12.1 opt-ex12_1.htm EX-12.1 16772
7 EX-12.2 opt-ex12_2.htm EX-12.2 16493
8 EX-13.1 opt-ex13_1.htm EX-13.1 12402
9 EX-15.1 opt-ex15_1.htm EX-15.1 4873
10 GRAPHIC img93570987_0.jpg GRAPHIC 4656
  Complete submission text file 0001193125-25-202743.txt   31505952

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT opt-20250630.xsd EX-101.SCH 2766330
169 EXTRACTED XBRL INSTANCE DOCUMENT opt-20250630_htm.xml XML 8457501
Mailing Address LEVEL 4 650 CHAPEL STREET SOUTH YARRA VICTORIA Australia 3141
Business Address LEVEL 4 650 CHAPEL STREET SOUTH YARRA VICTORIA Australia 3141 61 3 9826 0399
Opthea Ltd (Filer) CIK: 0001815620 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 001-39621 | Film No.: 251313140
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)